“Just Because It’s Legal, Doesn’t Mean It’s Safe”

Interviews with people who murdered their own loved ones while taking SSRI antidepressants are included in the documentary, "Dark Side of a Pill." More →

Categorized In:

Centers For Medicare & Medicaid Keep Pushing To Reduce Antipsychotic Use In Elderly

McKnight's reports that, "The push for long-term care facilities to abandon the use of off-label use of antipsychotic medications for residents with dementia will intensify over the next two years, Centers for Medicare & Medicaid Services officials said." More →

Categorized In:

Antidepressants Worsen Rapid-Cycling in Bipolar Depression

SSRI antidepressant medications contribute to a significant worsening of emotional "rapid cycling" in patients diagnosed with bipolar disorder, according to a study published in the Journal of Affective Disorders. The authors described the study as the first-ever randomized clinical trial to test whether the finding from previous observational studies was true, and stated that the study clarified the "lack of safety" of antidepressants for some people with bipolar. More →

Categorized In:

Slew of New Studies Spot Links Between Psychiatric Medications and Bone Loss, Fractures

Four different studies conducted in different ways examining different groups have linked use of certain psychiatric drugs, particularly SSRI antidepressants and antipsychotics but also benzodiazepines, to bone fracture risks and negative impacts on human bone development. More →

Categorized In:

Antidepressant-linked Suicide Data Doctored In Seminal Study

An influential 2007 US National Institute of Mental Health-led study included a statistical manipulation that disguised the fact that youth taking antidepressants were actually over four times as likely to experience suicidal events as those taking placebo, according to a study in the International Journal of Risk & Safety in Medicine. This new published analysis has appeared several years after the revelations were first publicly discussed. More →

Categorized In:

Clozapine-induced Stuttering Affects 1% Of Patients

A team of psychiatrists from Ireland has found that nearly 1% of patients who take the antipsychotic clozapine experience clozapine-induced stuttering. In Therapeutic Advances in Psychopharmacology, they also described how to eliminate the problem. More →

Categorized In:

Will Cognitive Enhancers Soon Become Necessary Work Steroids?

Many ordinary people from video gamers, students and neuroscientists to entrepreneurs, classical musicians, and public servants are using stimulants in the absence of solid evidence about safety, recounts an article in The Conversation. So what might the repercussions for our competitive society look like if we develop a cognitive-enhancer drug that actually works over the long term? More →

Categorized In:

Antipsychotic Dose Reduction Linked To Long-term Improvements In First-Episode Schizophrenia Patients

Careful reductions in dosage levels of antipsychotic medications over time improved long-term rates of recovery and functional remission in patients diagnosed with a first-episode psychosis, according to a study led by Lex Wunderink reported in a Supplement of European Psychiatry. More →

Categorized In:

No Treatments Have “Clinically Meaningful” Impacts On Negative Symptoms of Schizophrenia

While most treatments have had "statistically significant" success in clinical trials, no common psychiatric or psychological treatments improve what are termed "negative" symptoms of schizophrenia at levels that are "clinically meaningful," according to a meta-analysis in Schizophrenia Bulletin. More →

Categorized In:

Pennsylvania Latest State To Try To Curb Psychotropic Prescribing To Foster Children

Like in many other states, foster children in Pennsylvania are being given psychotropic drugs by physicians at rates that are "disturbing" and "unacceptable," according to a press release and new report from the state's Department of Human Services (DHS). The state government also announced its plans to try to rein in the practice. More →

Categorized In:

“The Club Drug Emerging As A Popular Antidepressant”

In AlterNet, Chris Lyford looks at some of the science, politics and money associated with emerging interest in ketamine for treating depression. More →

Categorized In:

One-quarter of Ohio-area Children With Down Syndrome Are Being Prescribed Psychotropics

The odds of a child with Down syndrome being on a psychotropic medication increase steadily with age, according to a study in the Journal of Developmental & Behavioral Pediatrics. By the time they are teenagers, about 25% are taking one or more psychiatric drugs. More →

Categorized In:

Major Canadian Professional Psychiatric Groups Speak Out Against Overusing of Psychotropics

As part of its Choosing Wisely Canada campaign, a joint working group of the Canadian Psychiatric Association, the Canadian Academy of Child and Adolescent Psychiatry (CACAP), and the Canadian Academy of Geriatric Psychiatry has issued a 13-point list of recommendations to physicians for reducing the inappropriate use of psychotropic medications. More →

Categorized In:

Antidepressants During Pregnancy Do Not Appear To Reduce Relapses And Hospitalizations

Continuing to take antidepressants during pregnancy was associated with higher rates of depressive relapses, hospitalizations and self-harming than stopping antidepressants, according to a study in Pharmacoepidemiology and Drug Safety. More →

Categorized In:

House of Lords Speaker Addresses Harms From Psychiatric Drugs and Prescription Addictions

The Council for Evidence-based Psychiatry has published the text of a speech by the Earl of Sandwich in the British House of Lords. The Earl criticizes physicians and the government for not recognizing or helping people who are suffering long-term harms from psychiatric medications or who have become unwittingly addicted to certain psychotropics by following their doctors recommendations. More →

Categorized In:

Not an Onion Study: Underpowered Analysis Of Poor Quality Data Finds Antipsychotics Actually Aren’t Linked To Increased Risk Of Death In The Elderly

The studies that led to warnings from health regulators against prescribing antipsychotics to elderly patients with dementia were biased, and there is actually no significant increase in risk of death linked to the drugs, according to a study in the Journal of the American Medical Directors Association. To arrive at these findings, University of Groningen researchers explained that they focused their analysis on only small, short-term clinical trials with data of generally "poor" quality. More →

Categorized In:

“One Nation, Under Sedation”

ProPublica uses federal data and its online "Prescriber Checkup" tool to reveal that in 2013, when Medicare officially lifted its ban and started paying for benzodiazepine anti-anxiety drugs such as Valium, Xanax and Ativan, more than 40 million prescriptions worth more than $377 million were doled out. More →

Categorized In:

Many Teens Start Misusing Stimulants By Age 13

An equal percentage of young people will start misusing ADHD-related and other stimulant drugs for the first time at age 13, as will start at age 20, according to a study in Drug and Alcohol Dependence. The study challenges common beliefs that most stimulant misuse begins among college students, the author stated. More →

Categorized In:

Internal Pfizer Report Warned of Zoloft and Birth Defect Link

"A Pfizer Inc. report shows a scientist warned executives last year about a potential link between the anti-depressant drug Zoloft and birth defects, and recommended changes to the medication’s safety warning," reported Bloomberg. More →

Categorized In:

Psychotropics Linked to Worse Physical Problems and Mortality in Psychiatric Patients

Common psychotropic medications may be contributing to the higher rates of physical illnesses and mortality in people diagnosed with mental illnesses, according to a systematic review published in World Psychiatry. More →

Categorized In:

“Scientists Push to Renew Psychedelic Drug Research for Psychiatry”

On the CBC Radio show The Current, Anna Maria Tremonti interviews UK neuropsycho-pharmacologist David Nutt, Mark Haden of the Multidisciplinary Association for Psychedelic Studies and University of British Columbia, and Saskatchewan historian Erika Dyck about the past and present politics and science of psychiatric research with psychedelics. More →

Categorized In:

Antidepressants Kill Over 500,000 People Annually

A new study shows psychiatric drugs kill over half a million Americans and Europeans every year who are over 65. Professor Peter Gøtzsche claims efficacy trials underestimate the harmful effects of antidepressants, which in fact cause up to 15 time …
Full Article

Categorized In:

Antidepressants Tied To Increased Risk of Homicide “Only Modestly”; Benzodiazepines More So

Taking antidepressant or benzodiazepine medications are both associated with increased risks that a person will commit a homicide, according to a study from Finland published in a World Psychiatry letter. More →

Categorized In:

“Zap Mama: My Long, Slow, Dizzy Breakup With My Antidepressant”

Salon assistant editor Joanna Rothkopf describes her year of failed efforts to get off the antidepressant Zoloft. More →

Categorized In:

Germanwings Pilot Saw Psychiatrist Three Times, Doubled Antidepressant In Month Before Crash

The man who deliberately crashed a Germanwings commercial airliner with 150 passengers aboard was actively in psychiatric treatment at the time, reported the New York Times. More →

Categorized In: